EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis

Xiao-Yu Zhou, Chen-Hao Deng, Ji-Yuan Zhong, Qi Wu, Qing-Xin Chen, Xin-Yuan Gao, Yong Xu, Zong-Zhe Jiang, Man Guo, Fang-Yuan Teng

Nutrition, Metabolism and Cardiovascular Diseases · 2026-12 · 36 (12) · 104859

DOI: 10.1016/j.numecd.2026.104859 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-12. Verfasst von Xiao-Yu Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China; School of Clinic…. Hauptthemen laut MEDLINE: Tirzepatide, Diabetes Mellitus, Type 2, Obesity, Glucagon-Like Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Semaglutide and tirzepatide are widely used drugs in the treatment of metabolic diseases based on incretin-based therapy. However, evidence on coronary artery disease (CAD)-related outcomes has largely been derived from separate randomized trials with different control groups, and focused synthesis across CAD phenotypes remains limited. This study aimed to evaluate CAD-related outcomes reported in randomized controlled trials (RCTs) of semaglutide and tirzepatide in adults with type 2 diabetes (T2DM) and/or obesity. DATA SYNTHESIS: We systematically searched PubMed, Embase, Scopus, Web of Science, CENTRAL, and ClinicalTrials.gov from database inception to September 26, 2025, for RCTs evaluating subcutaneous semaglutide or tirzepatide in T2DM and/or obesity. Separate pooled analyses were performed for semaglutide and tirzepatide using random-effects models. Prespecified outcomes included the broad CAD-related composite, acute coronary syndrome (ACS), myocardial infarction (MI), unstable angina (UA), chronic coronary syndrome (CCS), angina pectoris, and trial-reported CAD events, defined as CAD events explicitly reported in the original trials. Among the 45 included trials, semaglutide showed lower pooled estimates for the broad CAD-related composite (RR = 0.80, 95% CI [0.73-0.87]; p < 0.001), ACS (RR = 0.77, 95% CI [0.70-0.85]; p < 0.001), MI (RR = 0.70, 95% CI [0.62-0.80]; p < 0.001), UA (RR = 0.82, 95% CI [0.70-0.96]; p = 0.017), and angina pectoris (RR = 0.73, 95% CI [0.60-0.89]; p = 0.002) in the pooled analyses. For tirzepatide, pooled estimates were not statistically significant for most CAD-related outcomes, including the broad CAD-related composite (RR = 0.74, 95% CI [0.52-1.07]; p = 0.110). A lower pooled estimate was observed for trial-reported CAD events in tirzepatide trials, but this finding was based on fewer events and was interpreted as exploratory. CONCLUSION: In semaglutide trials, treatment was associated with lower pooled risks across several CAD-related outcomes, particularly acute coronary phenotypes in adults with T2DM and/or obesity. Evidence for tirzepatide remained less precise because of fewer CAD-related events and limited CAD-specific outcome data. Further dedicated cardiovascular outcome trials, longer follow-up studies, and more standardized reporting of CAD-related outcomes are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatideDiabetes Mellitus, Type 2ObesityGlucagon-Like PeptidesCoronary Artery DiseaseIncretinsHypoglycemic AgentsHumansSemaglutideTreatment OutcomeFemaleMaleRisk AssessmentMiddle AgedRandomized Controlled Trials as TopicAgedAdultHeart Disease Risk FactorsDiabesity

Stichwörter der Autor:innen

Coronary artery diseaseMeta-analysisObesitySemaglutideTirzepatide

Substanzen

SemaglutideTirzepatideGlucagon-Like PeptidesIncretinsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China; School of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, 646000, Ch…
  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Department of Endocrinology, Peking University People's Hospital Qingdao Hospital, Qingdao, 266000, China.
  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China; Metabolic Vascular Diseases Key Laboratory of Sichuan Province, and Metabolic Vascular…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, X. Y., Deng, C. H., Zhong, J. Y., Wu, Q., Chen, Q. X., Gao, X. Y., Xu, Y., Jiang, Z. Z., Guo, M., & Teng, F. Y. (2026). Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 36(12), 104859. https://doi.org/10.1016/j.numecd.2026.104859

Vancouver

Zhou XY, Deng CH, Zhong JY, Wu Q, Chen QX, Gao XY, et al. Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(12):104859. doi:10.1016/j.numecd.2026.104859

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiao-Yu and Deng, Chen-Hao and Zhong, Ji-Yuan and Wu, Qi and Chen, Qing-Xin and Gao, Xin-Yuan and Xu, Yong and Jiang, Zong-Zhe and Guo, Man and Teng, Fang-Yuan},
  title = {Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  volume = {36},
  number = {12},
  pages = {104859},
  doi = {10.1016/j.numecd.2026.104859}
}
Kostenlos starten →